Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antineoplastons A10 and AS2-1 in PNET Outside CNS
NCT00003515Phase 2Terminated
- Sponsor
- Burzynski Research Institute
- Start
- Dec 1996
- Primary completion
- Jan 1997
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of antineoplaston A10, antineoplaston AS2-1 in primitive neuroectodermal tumor (PNET), sponsored by Burzynski Research Institute. Started Dec 1996; status: terminated.
02
Drugs
antineoplaston A10antineoplaston AS2-1
03
Conditions
primitive neuroectodermal tumor (PNET)
Beyond the preview
Go deeper on NCT00003515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003515.